Andrew Rosenberg, DVM, DACVD, provided an overview of Janus kinase inhibitors for treating canine atopic dermatitis ...

Healing from anxiety is not an overnight process, but with a client-centred, integrative approach, you can make meaningful strides toward regaining control over your life. You are not defined by your ...

DUBLIN and CHICAGO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), today announced that the U.S. Food and Drug Administration (FDA) has approved Iterum’s new ...

Viking Therapeutics (NASDAQ:VKTX) added ~18% on Thursday to reach a five-month high as Wall Street focused on updates on its obesity candidate VK2735, even as the company posted better-than ...

Summit Therapeutics stock shot higher this September in response to outstanding clinical-trial results. The company's lead candidate is a cancer therapy that's already approved in China.

Viking Therapeutics Inc (NASDAQ:VKTX) reported positive data from four clinical programs, including VK2735 for obesity and VK2809 for NASH and fibrosis. The Phase II VENTURE trial for VK2735 ...

The other two types, GA1 and GA2, are encoded by genes contained on large mobile genetic elements called integrative and ... consortia of bacteria for therapeutics need to account for the effects ...

They’re peppy, playful, and stars of the dog park. They’re Bichon Frises! The curious little pups look a lot like Toy Poodles, but Bichon Frises are usually a bit more outgoing with strangers. They’re ...

When video of a dog at the top of an Egyptian pyramid in Giza went viral last week, tens of millions of social media users were simultaneously delighted and baffled. How did the dog get up there ...

End-of-Phase 2 Meeting for Subcutaneous VK2735 for Obesity Planned for 4Q24 Phase 2 Study of Oral VK2735 in Obesity Expected to Begin 4Q24 Results of Phase 2b VOYAGE Study of VK2809 in NASH/MASH ...